Ibritumomab Intravenous and Morphine Long-Acting Tablets
Determining the interaction of Ibritumomab Intravenous and Morphine Long-Acting Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: morphine
Brand name: Arymo ER, Kadian, MorphaBond ER, MS Contin, Avinza, Duramorph PF, Infumorph, Mitigo, RMS, Roxanol
Synonyms: Morphine, Morphine (Systemic)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Morphine Oral Concentrate (20 mg/mL)
- Ibritumomab Intravenous-Morphine Oral Solution
- Ibritumomab Intravenous-Morphine Sulfate
- Ibritumomab Intravenous-Morphine Sulfate Injection
- Ibritumomab Intravenous-Morphine Sulfate Injection, Concentrate
- Ibritumomab Intravenous-Morphine Sulfate Solution, Concentrate
- Morphine Long-Acting Tablets-Ibritumomab Tiuxetan
- Morphine Long-Acting Tablets-Ibrutinib
- Morphine Long-Acting Tablets-Ibrutinib Capsules
- Morphine Long-Acting Tablets-Ibrutinib Tablets
- Morphine Long-Acting Tablets-Ibu
- Morphine Long-Acting Tablets-IBU Tablets